Thursday, July 7, 2016

BRIEF-Juno Therapeutics reports clinical hold on the JCAR015 Phase II rocket trial

* Says trials and plans for its other CD19-directed CAR-T

cell product candidates, including JCAR017, are not affected

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)